Cover Image
Market Research Report

Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019

Published by MarketsandMarkets Product code 322319
Published Content info 195 Pages
Delivery time: 1-2 business days
Price
Back to Top
Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019
Published: December 16, 2014 Content info: 195 Pages
Description

Over the last five years, the plasma fractionation market witnessed tremendous growth, primarily due to the growth in aging population, increasing number of hemophilic patients, rising use of IVIg, and high prevalence of chronic disorders across the globe.

In this report, the global plasma fractionation market is divided on the basis of product, application, and end user. Based on type of products, the plasma fractionation market is mainly segmented into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further subsegmented into intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg), and others. Coagulation factor concentrates are subsegmented into factor VIII, factor IX, factor XIII, prothrombin coagulation concentrates, Von Willebrand factor, and fibrinogen concentrates. The plasma fractionation application market is divided into neurology; hematology; immunology; critical care; and others. Likewise, the major end users analyzed in the plasma fractionation market are hospitals and clinics, clinical research laboratories, and academic institutes.

The global plasma market is expected to grow at a CAGR of 8.9% during the forecast period of 2014-2019. The market is mainly driven by the growth in aging population, increasing use of IVIg, growing number of hemophilic patients, and increasing diagnosis rate globally. However, the high cost of immunoglobulins and hemophilic drugs, stringent government regulations, and rapid increase in the use of recombinant products as an alternative to plasma-derived coagulation factor concentrates are hampering the growth of this market to a certain extent.

IVIg accounts for the major share of the plasma fractionation market. The increasing use of IVIg in clinical areas such as neurology, hematology, immunology, rheumatology, and dermatology, and its excellent efficacy records are the key factors responsible for the growth of this market segment. In addition, the use of IVIg is being evaluated for a wide range of conditions such as adult respiratory distress syndrome, fibrosis, connective tissue disease, encephalitis, heart failure, and Alzheimer's disease. Positive results in such conditions would increase the demand for IVIg globally in the near future.

In 2013,, North America contribute the largest share to the global plasma fractionation market, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market, which is expected to witness the fastest growth during the forecast period, largely driven by the increasing aging population, increasing use of immunoglobulins, improved economy, rising number of hemophilic patients, growing use of albumin in China, increased accessibility to healthcare facilities, growth in the overall healthcare industry, and growing awareness of technologically advanced products in these regions.

The global plasma fractionation market is mainly dominated by six players that accounted for around 70% of the global plasma fractionation market in 2013. The major players in the global plasma fractionation market are Baxter International, Inc. (U.S.), Grifols SA (Spain), CSL Ltd. (Australia), Octapharma AG (Switzerland), Kedrion (Italy), Bio Product Laboratory (U.K.), Sanquin (Netherland), Laboratoire Francais du Fractionnement et des Biotechnologies (France), and Biotest (Germany).

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by top players in the plasma fractionation market. The report analyzes the plasma products by products, applications, and end users across all regions.
  • Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the plasma fractionation market.
  • Market Development: Comprehensive information on the lucrative emerging markets by products, application, end users, and region.
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the plasma fractionation market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analysis of leading players in the plasma fractionation market.
Table of Contents
Product Code: BT 3042

Table of Contents

1. Introduction

  • 1.1. Objectives Of The Study
  • 1.2. Markets Covered
  • 1.3. Market Scope
  • 1.4. Stakeholders
  • 1.5. Years Considered In The Report
  • 1.6. Currency

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Market Size Estimation
  • 2.3. Market Breakdown And Data Triangulation
  • 2.4. Market Share Estimation
  • 2.5. Key Secondary Sources
  • 2.6. Key Data From Primary Sources
    • 2.6.1. Key Industry Insights
  • 2.7. Assumptions For The Study

3. Executive Summary

4. Premium Insights

5. Market Overview

  • 5.1. Introduction
  • 5.2. Key Market Drivers
    • 5.2.1. Aging Baby Boomers Population Worldwide
    • 5.2.2. Rising Healthcare Expenditure
    • 5.2.3. Increasing Disposable Incomes In Developing Countries Creates Demand
  • 5.3. Key Market Restraints
    • 5.3.1. High Cost And Limited Reimbursement Poses A Major Barrier To The Growth Of The Plasma Fractionation Market
    • 5.3.2. Stringent Government Regulations
    • 5.3.3. Economic Slowdown And Saturation To Inhibit The Growth
    • 5.3.4. Rising Number Of Recombinant Products
  • 5.4. Key Market Opportunities
    • 5.4.1. Increasing Number Of Hemophilic Patients
  • 5.5. Key Market Challenges
    • 5.5.1. Pricing Pressure Faced By Prominent Players In The Market
  • 5.6. Key Market Trends
    • 5.6.1. Increasing Market Consolidation
    • 5.6.2. Rising Adoption Of Scig
    • 5.6.3. Rising Number Of Plasma Collection Centers
    • 5.6.4. Increasing Number Of Local Players

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Porter's Five Forces Analysis
    • 6.2.1. Threat Of New Entrants
    • 6.2.2. Threat Of Substitutes
    • 6.2.3. Bargaining Power Of Suppliers
    • 6.2.4. Bargaining Power Of Buyers
    • 6.2.5. Intensity Of Competitive Rivalry
  • 6.3. Strategic Benchmarking
    • 6.3.1. Expansions

7. Global Plasma Fractionation Market, By Product

  • 7.1. Introduction
  • 7.2. Albumin
  • 7.3. Immunoglobulin
    • 7.3.1. Intravenous Immunoglobulin
    • 7.3.2. Subcutaneous Immunoglobulin
    • 7.3.3. Others
  • 7.4. Coagulation Factor Concentrates
    • 7.4.1. Factor VIII
    • 7.4.2. Factor IX
    • 7.4.3. Factor XIII
    • 7.4.4. Prothrombin Complex Concentrate
    • 7.4.5. Von Willebrand Factor (VWF)
    • 7.4.6. Fibrinogen Concentrates
  • 7.5. Protease Inhibitors
  • 7.6. Other Plasma Products

8. Global Plasma Fractionation Market, By Application

  • 8.1. Introduction
  • 8.2. Neurology
  • 8.3. Hematology
  • 8.4. Immunology
  • 8.5. Critical Care
  • 8.6. Others

9. Global Plasma Fractionation Market, By End User

  • 9.1. Introduction
  • 9.2. Hospitals And Clinics
  • 9.3. Clinical Research Laboratories
  • 9.4. Academic Institutes

10. Global Plasma Fractionation Market, By Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. Italy
    • 10.3.3. Spain
    • 10.3.4. France
    • 10.3.5. U.K.
    • 10.3.6. Roe
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. India
    • 10.4.4. Rest Of Asia-Pacific (RoAPAC)
  • 10.5. Rest Of The World
    • 10.5.1. Latin America
    • 10.5.2. Middle East And Africa

11. Competitive Landscape

  • 11.1. Overview
  • 11.2. Market Share Analysis
  • 11.3. Competitive Situation And Trends
    • 11.3.1. New Product Launches
    • 11.3.2. Expansions
    • 11.3.3. Mergers And Acquisitions
    • 11.3.4. Agreements, Partnerships, Collaborations, & Joint Ventures
    • 11.3.5. Other Developments

12. Company Profiles

  • 12.1. Baxter International, Inc.
    • 12.1.1. Business Overview
    • 12.1.2. Product Portfolio
    • 12.1.3. Key Strategy
    • 12.1.4. Recent Development
  • 12.2. Octapharma AG
    • 12.2.1. Business Overview
    • 12.2.2. Product Portfolio
    • 12.2.3. Key Strategy
    • 12.2.4. Recent Developments
  • 12.3. Biotest
    • 12.3.1. Business Overview
    • 12.3.2. Product Portfolio
    • 12.3.3. Key Strategy
    • 12.3.4. The Recent Developments
  • 12.4. Csl, Ltd.
    • 12.4.1. Business Overview
    • 12.4.2. Product Portfolio
    • 12.4.3. Key Strategy
    • 12.4.4. Recent Developments
  • 12.5. Grifols International SA
    • 12.5.1. Business Overview
    • 12.5.2. Product Portfolio
    • 12.5.3. Key Strategy
    • 12.5.4. Recent Developments
  • 12.6. Kedrion S.P.A.
    • 12.6.1. Business Overview
    • 12.6.2. Product Portfolio
    • 12.6.3. Key Strategy
    • 12.6.4. Recent Developments
  • 12.7. LFB SA
    • 12.7.1. Business Overview
    • 12.7.2. Product Portfolio
    • 12.7.3. Key Strategy
    • 12.7.4. Recent Developments
  • 12.8. Kedrion
    • 12.8.1. Business Overview
    • 12.8.2. Product Portfolio
    • 12.8.3. Key Strategy
    • 12.8.4. Recent Developments
  • 12.9. Chinese Biological Products, Inc.
    • 12.9.1. Business Overview
    • 12.9.2. Product Portfolio
    • 12.9.3. Key Strategy
    • 12.9.4. Recent Developments
  • 12.1. Shanghai Raas Blood Products Co., Ltd.
    • 12.10.1. Business Overview
    • 12.10.2. Product Portfolio
    • 12.10.3. Key Strategy
    • 12.10.4. Recent Developments

13. Appendix

  • 13.1. Insights Of Industry Experts
  • 13.2. Discussion Guide
  • 13.3. Available Customizations
  • 13.4. Related Reports
  • 13.5. Introducing RT: Real-Time Market Intelligence

List of Tables

  • Table 1: Demographic Growth Trends Of Elderly Population
  • Table 2: Global Plasma Fractionation Market Size, By Product, 2012-2019 ($Million)
  • Table 3: Global Market Size, By Geography, 2012-2019 ($Million)
  • Table 4: Global Albumin Market Size, By Geography, 2012-2019 ($Million)
  • Table 5: Global Immunoglobulin Market Size, By Type 2012-2019 ($Million)
  • Table 6: Global Immunoglobulin Market Size, By Geography 2012-2019 ($Million)
  • Table 7: Global Ivig Market Size, By Geography 2012-2019 ($Million)
  • Table 8: Global Scig Market Size, By Geography 2012-2019 ($Million)
  • Table 9: Global Others Immunoglobulin Market Size, By Geography 2012-2019 ($Million)
  • Table 10: Global Cogulation Factor Concentrates Market Size, By Type 2012-2019 ($Million
  • Table 11: Global Cogulation Factor Concentrates Market Size, By Geography 2012-2019 ($Million)
  • Table 12: Global Factor Viii Market Size, By Geography 2012-2019 ($Miilion)
  • Table 13: Global Factor Ix Market Size, By Geography 2012-2019 ($Million)
  • Table 14: Global Factor Xiii Market Size, By Geography 2012-2019 ($Million)
  • Table 15: Global Pcc Market Size, By Geography 2012-2019 ($Million)
  • Table 16: Global Vwf Market Size, By Geography 2012-2019 ($Million)
  • Table 17: Fibrinogen Concentrates Market Size, By Geography 2012-2-19 ($Million)
  • Table 18: Global Protease Inhibitors Market Size, By Geography 2012-19 ($Million)
  • Table 19: Global Other Plasma Products Market Size, By Geography 2012-2019 ($Million)
  • Table 20: Plasma Fractionation Market Size, By Application 2012-2019 ($Million)
  • Table 21: Market Size, For Neurology, 2012-2019 ($Million)
  • Table 22: Market Size, For Hematology, 2012-2019 ($Million)
  • Table 23: Market Size, For Immunology, 2012-2019 ($Million)
  • Table 24: Market, For Critical Care, 2012-2019 ($Million)
  • Table 25: Market, For Others, 2012-2019 ($Million)
  • Table 26: Plasma Fractionation Market, By End Users, 2012-19 ($Million)
  • Table 27: Global Plasma Fractionation Market Size For Hospitals And Clinics, By Country/Region, 2012-2019 ($Million)
  • Table 28: Global Market Size For Clinical Research Laboratories, 2012-2019 ($Million)
  • Table 29: Global Plasma Fractionation Market Size For Academic Organizations, 2012-2019 ($Million)
  • Table 30: North America: Market Size, By Country, 2012-2019 ($Million)
  • Table 31: North America: Market Size, By Products, 2012-2019 ($Million)
  • Table 32: North America: Immunoglobulin Market Size, By Product, 2012-2019 ($Million)
  • Table 33: North America: Coagulation Factor Concentrates Market Size, By Product, 2012-2019 ($Million)
  • Table 34: North America: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 35: North America: Market, By End User, 2012-2019 ($Million)
  • Table 36: U.S.: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 37: U.S.: Immunoglobulin Market Size, By Product, 2012-2019 ($Million)
  • Table 38: U.S.: Coagulation Factor Concentrates Market Size, By Product, 2012-2019 ($Million)
  • Table 39: U.S.: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 40: U.S.: Market Size, By End User, 2012-2019 ($Million)
  • Table 41: Canada: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 42: Canada: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 43: Canada: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 44: Canada: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 45: Canada: Market Size, By End Users, 2012-2019 ($Million)
  • Table 46: Europe: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 47: Europe: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 48: Europe: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 49: Europe: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 50: Europe: Market Size, By End Users, 2012-2019 ($Million)
  • Table 51: Germany: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 52: Germany: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 53: Germany: Coagulation Factor Concentrates Market Size, 2012-2019 ($Million)
  • Table 54: Germany: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 55: Germany: Market Size, By End User, 2012-2019 ($Million)
  • Table 56: Italy: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 57: Italy: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 58: Italy: Coagulation Factor Concentrates Market Size, 2012-2019 ($Million)
  • Table 59: Italy: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 60: Italy: Market, By End User, 2012-2019 ($Million)
  • Table 61: Spain: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 62: Spain: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 63: Spain: Coagulation Factor Concentrates Market Size, 2012-2019 ($Million)
  • Table 64: Spain: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 65: Spain: Market, By End User, 2012-2019 ($Million)
  • Table 66: France: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 67: France: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 68: France: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 69: France: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 70: France: Market Size, By End User, 2012-2019 ($Million)
  • Table 71: U.K.: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 72: U.K.: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 73: U.K.: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 74: U.K.: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 75: U.K.: Market Size, By End Users, 2012-2019 ($Million)
  • Table 76: ROE: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 77: ROE: Immunoglobulin Market Size, By Products, 2012-19 ($Million)
  • Table 78: ROE: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 79: ROE: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 80: ROE: Market Size, By End Users, 2012-2019 ($Million)
  • Table 81: Asia-Pacific: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 82: Asia-Pacific: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 83: Asia-Pacific: Coagulation Factor Concentrate Market Size, By Products, 2012-2019 ($Million)
  • Table 84: Asia-Pacific: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 85: Asia-Pacific: Market Size, By End Users, 2012-2019 ($Million)
  • Table 86: Japan: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 87: Japan: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 88: Japan: Coagulation Factor Concentrates Size, By Products, 2012-2019 ($Million)
  • Table 89: Japan: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 90: Japan: Market Size, By End Users, 2012-2019 ($Million)
  • Table 91: China: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 92: China: Immunological Market Size, By Products, 2012-19 ($Million)
  • Table 93: China: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 94: China: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 95: China: Market Size, By End Users, 2012-2019 ($Million)
  • Table 96: India: Plasma Fractionation Market Size, By Products 2012-19 ($Million)
  • Table 97: India: Immunoglobulin Market Size, By Products 2012-19 ($Million)
  • Table 98: India: Coagulation Factor Concentrates Market Size, By Products 2012-2019 ($Million)
  • Table 99: India: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 100: India: Plasma Fractionation Market Size, By Products 2012-2019 ($Million)
  • Table 101: Rest Of Asia-Pacific: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 102: Rest Of Asia-Pacific: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 103: Rest Of Asia-Pacific: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 104: Rest Of Asia-Pacific: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 105: Rest Of Asia-Pacific: Market Size, By End Users, 2012-2019 ($Million)
  • Table 106: ROW: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 107: ROW: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 108: ROW: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 109: ROW: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 110: ROW: Market Size, By End Users, 2012-2019 ($Million)
  • Table 111: Latin America: Market Size, By Products, 2012-2019 ($Million)
  • Table 112: Latin America: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 113: Latin America: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 114: Latin America: Plasma Fractionation Market Size, By Applications, 2012-2019 ($Million)
  • Table 115: Latin America: Market Size, By End Users, 2012-2019 ($Million)
  • Table 116: Middle East And Africa: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 117: Middle East And Africa: Immunoglobulin Market Size, By Products, 2012-2019 ($Million)
  • Table 118: Middle East And Africa: Coagulation Factor Concentrates Market Size, By Products, 2012-2019 ($Million)
  • Table 119: Middle East And Africa: Plasma Fractionation Market Size, By Products, 2012-2019 ($Million)
  • Table 120: Middle East And Africa: Market Size, By End Users, 2012-2019 ($Million)
  • Table 121: Growth Strategy Matrix, 2010-2014
  • Table 122: New Product Launches, 2011-2013
  • Table 123: Expansions, 2011-2014
  • Table 124: Mergers And Acquisitions, 2011-2014
  • Table 125: Agreements, Partnerships, Collaborations, And Joint Ventures, 2012-2014
  • Table 126: Other Developments, 2012-2014

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Breakdown Of Primary Interviews: By Company Type, Designation, And Region
  • Figure 3: Bottom-Up Approach
  • Figure 4: Top-Down Approach
  • Figure 5: Data Triangulation Methodology
  • Figure 6: Evolution
  • Figure 7: Immunoglobulins To Dominate Market During Forecast Period
  • Figure 8: Major Markets Of Plasma Fractionation Market
  • Figure 9: Immunoglobulins Are The Fastest-Growing Segment During Forecast Period
  • Figure 10: Asia- Pacific To Grow At The Fastest Rate In The Next Five Years
  • Figure 11: Expansions, The Key Growth Strategy Adopted By Majority Of Leading Players To Sustain Their Market Share
  • Figure 12: Attractive Growth Opportunity In The Plasma Fractionation Market
  • Figure 13: Immunoglobulins Account For More Than One Third Of The Apac Plasma Fractionation Market
  • Figure 14: U.S. Commands More Than One-Third Of The Global Market
  • Figure 15: North America Dominates The Market
  • Figure 16: Market Developed Vs. Developing Countries
  • Figure 17: Increased Consolidation For Improvement Of Product Portfolio Are The Leading Trends In This Industry
  • Figure 18: Porter's Five Forces Analysis - Reference
  • Figure 19: Strategic Benchmarking: Grifols International Sa And Octapharma Ag Largely Adopted Organic Growth Strategies For Expansions
  • Figure 20: Hospital And Clinics Will Continue To Dominate The Global Market In 2012-2019
  • Figure 21: Geographic Snapshot (2014-2019) - Rapid Growth Markets Are Emerging As New Hot Spots
  • Figure 22: Immunoglobulin Offers High Growth Potential For Almost All Product Categories
  • Figure 23: North America Plasma Fractionation Market Snapshot: Growth Will Be Driven By Rising Demand For Plasma Products And Development Of New Products Development
  • Figure 24: Germany Is The Major Market For Plasma Fractionation In Europe
  • Figure 25: Apac Plasma Fractionation Market Snapshot - China Is The Most Lucrative Market
  • Figure 26: Companies Adopted Expansion As A Key Growth Strategy
  • Figure 27: Global Plasma Fractionation Market Share Analysis, By Key Player, 2013
  • Figure 28: Battle For Market Share: Expansion Was The Key Strategy
  • Figure 29: Baxter International Inc.: Company Snapshot
  • Figure 30: Octapharma: Company Snapshot
  • Figure 31: Biotest: : Company Snapshot
  • Figure 32: Csl Ltd.: Company Snapshot
  • Figure 33: Grifols International Sa: Company Snapshot
  • Figure 34: Kedrion S.P.A.: Company Snapshot
  • Figure 35: Lfb Sa: Company Snapshot
  • Figure 36: Kedrion: Company Snapshot
  • Figure 37: Chinese Biological Products Inc.: Company Snapshot
  • Figure 38: Shanghai Raas Blood Products Co., Ltd. : Company Snapshot
Back to Top